Andrew Knudten - AveXis Sr. VP of Manufacturing and Supply Chain
SVP
Mr. Andrew F. Knudten is Senior Vice President Manufacturing and Supply Chain of the company., since September 2015. Previously, Mr. Knudten served as vice president of operations and vice president of active pharmaceutical ingredient operations at Hospira, Inc. from March 2012 to September 2015, where he had overall global responsibility for the company API business. Mr. Knudten also previously served as global head of contract manufacturing and strategy for Novartis Vaccines and Diagnostics, Inc. from February 2009 to March 2012, and as vice president of manufacturing at CoDa Therapeutics, Inc. from September 2007 to February 2009. From 1994 to 2007, he served in various research, product development, finance and operations roles at Amgen Inc., supporting the development of numerous pipeline products and more than five eventual commercial products now being marketed by Amgen since 2015.
| Age | 48 |
| Tenure | 9 years |
| Professional Marks | MBA |
| Phone | 847 572-8280 |
| Web | www.avexis.com |
AveXis Management Efficiency
AveXis' management efficiency ratios could be used to measure how well AveXis manages its routine affairs as well as how well it operates its assets and liabilities. AveXis, Inc., a clinical-stage gene therapy company, engages in developing and commercializing treatments for patients suffering from rare and life-threatening neurological genetic diseases. AveXis, Inc. was founded in 2010 and is headquartered in Bannockburn, Illinois. AveXis operates under Biotechnology classification in USA and traded on NASDAQ. It employs 219 people. AveXis Inc (AVXS) is traded on NASDAQ Exchange in USA and employs 219 people.Management Performance
| Return On Equity | -0.0073 | |||
| Return On Asset | -1.0E-4 |
AveXis Inc Leadership Team
Elected by the shareholders, the AveXis' board of directors comprises two types of representatives: AveXis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AveXis. The board's role is to monitor AveXis' management team and ensure that shareholders' interests are well served. AveXis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AveXis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Carole Nuechterlein, Independent Director | ||
| Michael Johannesen, Senior Vice President Chief Compliance Officer, General Counsel | ||
| Daniel Welch, Independent Chairman of the Board | ||
| Rick Modi, Senior Vice President Chief Business Officer | ||
| Phillip Donenberg, Principal Financial Officer, Senior Vice President Principal Accounting Officer | ||
| Andrew Knudten, Sr. VP of Manufacturing and Supply Chain | ||
| James LItalien, Senior Vice President - Chief Regulatory and Quality Officer | ||
| Joao Siffert, Director | ||
| Lori Smith, Chief Human Resource Officer, Senior Vice President | ||
| Jim Goff, Vice President Investor Relations and Corporate Communications | ||
| Thomas Dee, CFO and Sr. VP | ||
| Jonathan Leff, Independent Director | ||
| Sukumar Nagendran, Senior Vice President and Chief Medical Officer | ||
| Terrence Kearney, Independent Director | ||
| Frank Verwiel, Independent Director | ||
| Bong Koh, Independent Director | ||
| Brian Kaspar, Chief Scientific Officer, Member of Scientific Advisory Board and Director | ||
| Sukumar MD, Chief Medical Officer and Sr. VP | ||
| Sean Nolan, CEO and President and Director | ||
| Paul Manning, Independent Director | ||
| Session, Senior Vice President - Corporate Strategy and Project Management |
AveXis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AveXis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0073 | |||
| Return On Asset | -1.0E-4 | |||
| Current Valuation | 7.43 B | |||
| Shares Outstanding | 36.82 M | |||
| Shares Owned By Insiders | 16.87 % | |||
| Shares Owned By Institutions | 83.26 % | |||
| Number Of Shares Shorted | 3.99 M | |||
| Price To Earning | (20.13) X | |||
| Price To Book | 21.01 X | |||
| EBITDA | (218.1 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AveXis in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AveXis' short interest history, or implied volatility extrapolated from AveXis options trading.
Pair Trading with AveXis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AveXis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AveXis will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Moodys could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Moodys when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Moodys - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Moodys to buy it.
The correlation of Moodys is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Moodys moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Moodys moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Moodys can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in AveXis Stock
If you are still planning to invest in AveXis Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AveXis' history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Correlations Find global opportunities by holding instruments from different markets |